Epic Trust Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$423K Buy
1,354
+127
+10% +$37.3K 0.47% 51
2024
Q1
$349K Buy
1,227
+16
+1% +$4.68K 0.43% 64
2023
Q4
$349K Sell
1,211
-70
-5% -$19.1K 0.47% 58
2023
Q3
$344K Sell
1,281
-94
-7% -$23.5K 0.54% 55
2023
Q2
$305K Buy
1,375
+36
+3% +$8.35K 0.43% 59
2023
Q1
$324K Buy
+1,339
New +$329K 0.39% 69

Other funds holding AMGN

Epic Trust Investment Advisors's AMGN Position: Q2 2024 in Review

Epic Trust Investment Advisors increased its Amgen (AMGN) stake by 10% in Q2 2024, buying an estimated $37.3K and bringing the position to 1,354 shares worth $423K. The position accounts for 0.47% of the portfolio, ranked #51.

Epic Trust Investment Advisors first reported a position in AMGN in Q1 2023 and has held it in 6 quarters since. 2,785 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.

  • Epic Trust Investment Advisors held 1,354 shares of Amgen worth $423K as of Q2 2024.
  • Epic Trust Investment Advisors bought 127 Amgen shares in Q2 2024, an estimated $37.3K.
  • Amgen made up 0.47% of Epic Trust Investment Advisors's portfolio in Q2 2024, its #51 holding.
  • Epic Trust Investment Advisors first reported a position in Amgen in Q1 2023 and has held it in 6 quarters since.
  • 2,785 funds tracked by Wall St. Rank held Amgen as of Q2 2024.

Based on Epic Trust Investment Advisors's 13F filing for Q2 2024, filed 17 Jul 2024.